TipRanks
Chordia Therapeutics Inc. (JP:190A)
:190A
Japanese Market
Want to see JP:190A full AI Analyst Report?

Chordia Therapeutics Inc. (190A) Financial Statements

2 Followers

Chordia Therapeutics Inc. Financial Overview

Chordia Therapeutics Inc.'s market cap is currently ¥3.79B. The company's EPS TTM is ¥-19.74; its P/E ratio is -2.48; Chordia Therapeutics Inc. is scheduled to report earnings on October 15, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 26Aug 25Aug 24Aug 23Aug 22
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 0.00¥ 2.50B¥ 0.00
Gross Profit¥ 0.00¥ -1.43B¥ -4.09M¥ 2.49B¥ -3.15M
Operating Income¥ -1.47B¥ -1.79B¥ -1.80B¥ 212.06M¥ -1.84B
EBITDA¥ -1.47B¥ -1.79B¥ -1.82B¥ 218.10M¥ -1.77B
Net Income¥ -1.46B¥ -1.79B¥ -1.83B¥ 223.34M¥ -1.78B
Balance Sheet
Cash & Short-Term Investments¥ 2.05B¥ 2.55B¥ 4.33B¥ 4.80B¥ 4.25B
Total Assets¥ 2.11B¥ 2.68B¥ 4.63B¥ 4.91B¥ 4.50B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -2.05B¥ -2.55B¥ -4.33B¥ -4.80B¥ -4.25B
Total Liabilities¥ 188.84M¥ 244.34M¥ 471.07M¥ 408.24M¥ 221.41M
Stockholders' Equity¥ 1.93B¥ 2.44B¥ 4.16B¥ 4.50B¥ 4.28B
Cash Flow
Free Cash Flow¥ -1.42B¥ -1.84B¥ -1.94B¥ 543.01M¥ -1.72B
Operating Cash Flow¥ -1.42B¥ -1.84B¥ -1.94B¥ 543.73M¥ -1.70B
Investing Cash Flow¥ -2.28M¥ -5.33M¥ -10.96M¥ 345.00K¥ -14.70M
Financing Cash Flow¥ 924.13M¥ 61.58M¥ 1.48B¥ 0.00¥ 3.98B
Currency in JPY

Chordia Therapeutics Inc. Earnings and Revenue History

Chordia Therapeutics Inc. Debt to Assets

Chordia Therapeutics Inc. Cash Flow

Chordia Therapeutics Inc. Forecast EPS vs Actual EPS